RxDoctor Payments Data

Erica Rosa, APRN

Family · Atlantis, FLNPI 1619574795

Payments from drug & device makers

$3,079in general payments, 2019–2025

Across 134 payments — averaging $22.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$534
  • AstraZeneca$461
  • Takeda Pharmaceuticals U.S.A., Inc.$313
  • Actelion Pharmaceuticals US, Inc.$266
  • Boehringer Ingelheim$251
  • Grifols USA, LLC$249
  • plus $1K from 18 others

What the payments were for

  • Food & beverage$2,87493%
  • Education$2057%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,079 in reported general payments places this provider in the 85th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$21,383
Medicare patients
151
Services billed
294

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter152$173,202
Breztri AerosphereBudesonide/Glycopyr/Formoterol24$23,289
SymbicortBudesonide/Formoterol Fumarate13$4,761
Albuterol Sulfate HfaAlbuterol Sulfate122$3,372
Montelukast Sodium120$1,071
Ipratropium Bromide27$716
Doxycycline Hyclate108$646
Prednisone131$439
Methylprednisolone35$228
Nystatin15$118
Azithromycin13$66

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$534$173,202152 claims
AstraZenecaBreztri Aerosphere, Symbicort$461$28,05037 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 14,618 family providers in Florida.

Other family in Atlantis

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →